COMMUNIQUÉS West-GlobeNewswire

-
Kalytera Confirms No Material Change in Operations
05/12/2017 -
ABILITY Network Helps Skilled Nursing Providers Streamline the Triple Check Process
05/12/2017 -
Texas Health IT company wants to make the US healthcare market competitive again
05/12/2017 -
RedHill Biopharma Provides 2017 Year-End Business Update
05/12/2017 -
Transactions concluded by management
05/12/2017 -
Adverum Biotechnologies Begins Patient Enrollment in the ADVANCE Phase 1/2 Clinical Trial for A1AT Deficiency
05/12/2017 -
Chembio Receives $8.5 Million Commitment from Bio-Manguinhos to Purchase Components for Production of DPP® Assays in Brazil during 2018
05/12/2017 -
Mateon Announces Preclinical Data Indicating Enhanced Tumor Immune Response of CA4P with Checkpoint Inhibitor
05/12/2017 -
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
05/12/2017 -
Novan Announces First Patient Dosed in Phase 1b Atopic Dermatitis Trial with SB414
05/12/2017 -
Antibacterial Benefits of PEKK for Orthopedic Applications Detailed in Study of 3D-Printed OsteoFab® Structures
05/12/2017 -
Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Diseases With Unmet Medical Needs
05/12/2017 -
Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors
05/12/2017 -
100% of Prostate Cancer Patients Completing 31-Week Post-Therapy Exam After Treatment with OncBioMune Immunotherapy Show No Disease Progression
05/12/2017 -
Galectin Therapeutics Announces Results from Phase 2b NASH-CX Trial
05/12/2017 -
BIOLIFE4D Comments on New Guidelines for High Blood Pressure in Adults
05/12/2017 -
Tyme Provides Update on At-The-Market Financing Activity
05/12/2017 -
Ovid Therapeutics Announces TAK-935/OV935 Has Received Orphan Drug Designation from U.S. FDA for Treatment of Dravet Syndrome
05/12/2017 -
CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Medicine for β-Thalassemia and Sickle Cell Disease, at the ASH Annual Meeting
05/12/2017
Pages